184 related articles for article (PubMed ID: 31109596)
21. Mining TCGA and GEO databases for the prediction of poor prognosis in lung adenocarcinoma based on up-regulated expression of TNS4.
Liu F; Gao X; Liu W; Xue W
Medicine (Baltimore); 2022 Oct; 101(42):e31120. PubMed ID: 36281194
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
[TBL] [Abstract][Full Text] [Related]
23. Integrative bioinformatics analysis the clinical value of KMT5A in different subtypes of lung cancer.
Liu S; Tian W; Li B
Comput Biol Chem; 2022 Feb; 96():107603. PubMed ID: 34894606
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
Zhang L; Zhang Z; Yu Z
J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
Guo CY; Zhu Q; Tou FF; Wen XM; Kuang YK; Hu H
BMC Cancer; 2019 Mar; 19(1):289. PubMed ID: 30925904
[TBL] [Abstract][Full Text] [Related]
26. Elevated integrin α6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
Shen J; Xu J; Chen B; Ma D; Chen Z; Li JC; Zhu C
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1681-1693. PubMed ID: 31175464
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma.
Wang S; Cai W; Li J; An W; Zheng H; Liao M
Biochem Genet; 2022 Dec; 60(6):1934-1945. PubMed ID: 35169964
[TBL] [Abstract][Full Text] [Related]
28. DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.
Luo J; Liu K; Yao Y; Sun Q; Zheng X; Zhu B; Zhang Q; Xu L; Shen Y; Ren B
Cancer Lett; 2019 Jul; 453():45-56. PubMed ID: 30928384
[TBL] [Abstract][Full Text] [Related]
29. High expression of DARS2 indicates poor prognosis in lung adenocarcinoma.
Jiang Y; You J; Wu C; Kang Y; Chen F; Chen L; Wu W
J Clin Lab Anal; 2022 Oct; 36(10):e24691. PubMed ID: 36085578
[TBL] [Abstract][Full Text] [Related]
30. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Su X; Wan Y; Xie L; Lin X; Zhao H; Ju X; Fang A
Med Sci Monit; 2019 Sep; 25():6691-6701. PubMed ID: 31489957
[TBL] [Abstract][Full Text] [Related]
31. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
32. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
[TBL] [Abstract][Full Text] [Related]
34. Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Li R; Gao Y; Qiu B; Tan F; Xue Q; Gao S; He J
DNA Cell Biol; 2020 Apr; 39(4):631-644. PubMed ID: 32096653
[TBL] [Abstract][Full Text] [Related]
35. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
Yu C; Hou L; Cui H; Zhang L; Tan X; Leng X; Li Y
Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998
[TBL] [Abstract][Full Text] [Related]
36. GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Sci Rep; 2021 Jun; 11(1):13281. PubMed ID: 34168239
[TBL] [Abstract][Full Text] [Related]
37. Elevated Expression of
Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
39. Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
Yang M; Sun Y; Sun J; Wang Z; Zhou Y; Yao G; Gu Y; Zhang H; Zhao H
Cancer Med; 2018 Apr; 7(4):1081-1092. PubMed ID: 29522283
[TBL] [Abstract][Full Text] [Related]
40. Rab27b Is a Potential Indicator for Lymph Node Metastasis and Unfavorable Prognosis in Lung Adenocarcinoma.
Zhang L; Fan W; Xu L; Mao Q; Chen Y; Mao Y; Xu L; Wang J
Dis Markers; 2018; 2018():7293962. PubMed ID: 30627227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
